Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysisZhenjie Wu, Riccardo Autorino, Peter C. Black et al.|European Urology|2022Cited by 99
Atorvastatin downregulates HSP22 expression in�an�atherosclerotic model in vitro and in vivoQi Chen, Yanqing Wu|International Journal of Molecular Medicine|2018Cited by 5